Lanoxin PG 50 micrograms/ml Elixir

Home
Medicines
Lanoxin PG 50 micrograms/ml Elixir

« Back to Medicines list

Name:
Lanoxin PG 50 micrograms/ml Elixir
Company:
Aspen
Active Ingredients:
Digoxin
Legal Category:
Product subject to medical prescription which may be renewed (B)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 22/01/19

(Click to Download)

XPIL

PACKAGE LEAFLET: INFORMATION FOR THE USER

1. What Lanoxin PG Elixir is and what it is used for

2. What you need to know before you use Lanoxin PG Elixir

3. How to take Lanoxin PG Elixir

4. Possible side effects

5. How to store Lanoxin PG Elixir

6. Contents of the pack and other information

Summary of Product Characteristics last updated on medicines.ie: 30/4/2019

Click on this link to Download PDF directly

Company Products

Medicine Name	Active Ingredients
Medicine Name Aldomet Tablets 250 mg	Active Ingredients Methyldopa
Medicine Name Aldomet tablets 500 mg	Active Ingredients Methyldopa
Medicine Name Alkeran 2 mg Film-coated Tablets	Active Ingredients Melphalan
Medicine Name Alkeran 50 mg, Powder and Solvent for Solution for Infusion	Active Ingredients Melphalan
Medicine Name Anectine 50 mg/ml Solution for Injection or Infusion	Active Ingredients Suxamethonium Chloride
Medicine Name Arixtra Fondaparinux sodium solution for injection 1,5 mg/ 0,3 ml	Active Ingredients Fondaparinux sodium
Medicine Name Arixtra Fondaparinux sodium solution for injection 10 mg/ 0,8 ml	Active Ingredients Fondaparinux sodium
Medicine Name Arixtra Fondaparinux sodium solution for injection 2,5 mg/ 0,5 ml	Active Ingredients Fondaparinux sodium
Medicine Name Arixtra Fondaparinux sodium solution for injection 5 mg/ 0,4 ml	Active Ingredients Fondaparinux sodium
Medicine Name Arixtra Fondaparinux sodium solution for injection 7,5 mg/ 0,6 ml	Active Ingredients Fondaparinux sodium
Medicine Name Dexamethasone 2mg Tablets	Active Ingredients Dexamethasone
Medicine Name Diprivan 1% w/v Emulsion for Injection or Infusion, Pre-filled Syringe (50ml)	Active Ingredients Propofol
Medicine Name Emla Cream 5%	Active Ingredients Lidocaine, Prilocaine
Medicine Name Fludrocortisone acetate 0.1mg Tablets	Active Ingredients Fludrocortisone Acetate
Medicine Name Imuran Powder for Solution for Injection or Infusion 50mg	Active Ingredients azathioprine sodium
Medicine Name Imuran Tablets 25mg	Active Ingredients Azathioprine
Medicine Name Imuran Tablets 50mg	Active Ingredients Azathioprine
Medicine Name Kemadrin Tablets	Active Ingredients Procyclidine Hydrochloride
Medicine Name Lanoxin 250 microgram tablets	Active Ingredients Digoxin
Medicine Name Lanoxin Injection	Active Ingredients Digoxin
Medicine Name Lanoxin PG 50 micrograms/ml Elixir	Active Ingredients Digoxin
Medicine Name Lanoxin PG Tablets	Active Ingredients Digoxin
Medicine Name Lanvis 40 mg tablets	Active Ingredients Tioguanine
Medicine Name Leukeran 2mg Film-coated Tablets	Active Ingredients Chlorambucil
Medicine Name Marcain 0.25% with Adrenaline (5 micrograms per ml) 1:200,000	Active Ingredients Adrenaline tartrate, Bupivacaine Hydrochloride

Items Per Page :

1 - 0 of 54 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 30 April 2019 SmPC

Reasons for updating

New SmPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 22 January 2019 PIL

Reasons for updating

Change to section 2 - what you need to know - warnings and precautions
Change to section 2 - interactions with other medicines, food or drink
Change to section 2 - excipient warnings
Change to section 3 - dose and frequency
Change to section 4 - possible side effects
Change to section 6 - date of revision

Updated on 5 February 2018 PIL

Reasons for updating

New PIL for new product

Updated on 5 February 2018 PIL

Reasons for updating

Change to section 5 - how to store or dispose
Change to section 6 - date of revision

Updated on 18 April 2017 PIL

Reasons for updating

Change to Section 1 - what the product is
Change to section 1 - what the product is used for
Change to section 2 - what you need to know - contraindications
Change to section 2 - what you need to know - warnings and precautions
Change to section 2 - use in children and adolescents
Change to section 2 - interactions with other medicines, food or drink
Change to section 2 - pregnancy, breast feeding and fertility
Change to section 2 - driving and using machines
Change to section 3 - dose and frequency
Change to section 3 - use in children/adolescents
Change to section 3 - how to take/use
Change to section 3 - duration of treatment
Change to section 3 - overdose, missed or forgotten doses
Change to section 4 - possible side effects
Change to section 4 - how to report a side effect
Change to section 6 - date of revision

Updated on 8 April 2014 PIL

Reasons for updating

Change to date of revision
Change to MA holder contact details

Updated on 19 November 2013 PIL

Reasons for updating

Change of active ingredient
Change to, or new use for medicine
Change to warnings or special precautions for use
Change to storage instructions
Change to side-effects
Change to information about pregnancy or lactation
Change to information about driving or using machinery
Change to date of revision
Change to dosage and administration
Addition of information on alternative format leaflets